Xicoy, Blanca <br/><br/>
Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes.  [electronic resource] 

 -  Leukemia & lymphoma  Jun 2014 
 - 1300-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2013.834532  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Azacitidine--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Myelodysplastic Syndromes--diagnosis<br/>Registries<br/>Treatment Outcome